Qiagen (QGEN) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Qiagen N.V. announced its Q1 2024 financial results, surpassing its sales outlook with $462 million at constant exchange rates, while maintaining a strong adjusted operating income margin of 25.7%. Despite a 5% decline in sales, the company has upheld its full-year guidance with expected net sales of at least $2.0 billion and adjusted diluted EPS of at least $2.10. Highlighting resilience amidst a tough economic environment, Qiagen’s diagnostics and efficiency gains continue to drive growth and investor confidence.
For further insights into QGEN stock, check out TipRanks’ Stock Analysis page.